Shares of ConvaTec Group Plc (LON:CTEC) have received an average recommendation of “Hold” from the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is GBX 249 ($3.38).
Several research analysts have commented on CTEC shares. Royal Bank of Canada decreased their target price on shares of ConvaTec Group from GBX 213 ($2.89) to GBX 195 ($2.65) and set an “underperform” rating for the company in a research report on Wednesday, November 24th. Barclays upped their target price on shares of ConvaTec Group from GBX 275 ($3.73) to GBX 290 ($3.94) and gave the stock an “overweight” rating in a research report on Monday, November 1st. JPMorgan Chase & Co. restated an “overweight” rating on shares of ConvaTec Group in a research report on Tuesday, January 4th. Shore Capital restated a “buy” rating on shares of ConvaTec Group in a research report on Friday, October 29th. Finally, Citigroup reiterated a “neutral” rating and issued a GBX 235 ($3.19) price objective on shares of ConvaTec Group in a report on Monday, November 1st.
CTEC opened at GBX 176.15 ($2.39) on Friday. ConvaTec Group has a fifty-two week low of GBX 175.85 ($2.39) and a fifty-two week high of GBX 265 ($3.60). The company has a quick ratio of 1.83, a current ratio of 2.48 and a debt-to-equity ratio of 89.87. The firm has a market cap of £3.55 billion and a price-to-earnings ratio of 35.23. The company’s 50-day moving average price is GBX 196.71 and its 200 day moving average price is GBX 217.05.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.